Archean Sciences, Inc.
PrivateLast Round
Seed
Aug 13, 2026
Total Funding Raised
$120,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Archean Sciences, Inc. operates in Healthcare & Life Sciences and is based in Champaign, Illinois. Its latest recorded funding round was a Grant round in April 2026.
Archean Sciences, Inc. is a biotechnology company that develops autonomous brain-on-a-chip systems by interfacing living neurons with advanced hardware and software to support therapeutic discovery, biological computing, and neural interfaces.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Computing Hardware
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Archean Sciences, Inc. Comparables
Compare Archean Sciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FinalSpark | 77% | |
| 2ndB | 76% | |
| 28bio | 76% |
For institutional investors. Book with your work email.
Archean Sciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 13, 2026 | ||||
| Grant | Apr 17, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Archean Sciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TechNexus Venture Collaborative | Grant, Seed |
| Origin Ventures Group | Grant, Seed |
| Sweet Spot Capital | Seed |
| Multimodal Ventures | Seed |
| Automated Deal Investing Network | Seed |
| Illinois Ventures | Grant, Seed |
| NSF I-Corps Program | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2026
$385K raised in Seed Round.
- Apr 17, 2026
$120K grant round closed with Illinois Ventures, Origin Ventures, and TechNexus.
For institutional investors. Book with your work email.
Archean Sciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Archean Sciences, Inc.'s valuation, stock price, and market status.
Is Archean Sciences, Inc. a public or private company?
Archean Sciences, Inc. is a private company.
What is the current stock price of Archean Sciences, Inc.?
Archean Sciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Archean Sciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Archean Sciences, Inc. worth (valuation)?
Valuation information for Archean Sciences, Inc. is not publicly available.
Can I buy Archean Sciences, Inc. stock?
Archean Sciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Archean Sciences, Inc.'s last funding round?
Archean Sciences, Inc.'s most recent funding round was Seed on August 13, 2026.
Who are the main investors in Archean Sciences, Inc.?
Key investors in Archean Sciences, Inc. include TechNexus Venture Collaborative, Origin Ventures Group, Sweet Spot Capital, Multimodal Ventures, Automated Deal Investing Network.
Will Archean Sciences, Inc. IPO soon?
No public IPO plans have been announced for Archean Sciences, Inc..
How can I track Archean Sciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Archean Sciences, Inc.'s shares on secondary markets.